Wise, 1958 - Google Patents
Principles of management of staphylococcic infectionsWise, 1958
- Document ID
- 6107493798673689198
- Author
- Wise R
- Publication year
- Publication venue
- Journal of the American Medical Association
External Links
Snippet
The results of antimicrobial therapy in patients with staphylococcic infections are difficult to evaluate for numerous reasons. These infections vary in severity from small pustules on the skin to overwhelming sepsis with bacteremia and formation of distant abscesses. Many …
- 201000009910 diseases by infectious agent 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hill et al. | Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak | |
| Patzakis et al. | The role of antibiotics in the management of open fractures | |
| Duckworth et al. | Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital | |
| Esterly et al. | The effect of antimicrobial agents on leukocyte chemotaxis | |
| Drancourt et al. | Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. | |
| Greenberg et al. | Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin | |
| Saroglou et al. | Methicillin-resistant Staphylococcus aureus: interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains | |
| Shamsuddin et al. | Bacillus cereus panophthalmitis: source of the organism | |
| Cohen et al. | Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment | |
| Barber | Hospital infection yesterday and today | |
| Ezer et al. | Intracellular bactericidal effects of rifampicin in both normal and chronic granulomatous disease polymorphs | |
| Wise | Principles of management of staphylococcic infections | |
| Ellison III et al. | Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections | |
| Howe | The problem of postoperative wound infections caused by staphylococcus aureus | |
| Hammerschlag et al. | In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis | |
| Pennekamp et al. | Mycobacterium smegmatis infection in a healthy woman following a facelift: case report and review of the literature | |
| McHenry et al. | Therapy with gentamicin for bacteremic infections: results with 53 patients | |
| Moore et al. | In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit | |
| JP2629166B2 (en) | Antibacterial agent effective against methicillin-resistant Staphylococcus aureus | |
| FINLAND et al. | Antibiotic Susceptibility and Phage Types of Pathogenic Staphylococci: A Study of Two Hundred Ten Strains Isolated at Boston City Hospital in 1955 | |
| Musher et al. | Treatment of cellulitis with ceforanide | |
| Chadwick | Resistance of Pseudomonas aeruginosa to gentamicin | |
| EA009169B1 (en) | Preparation containing allicin for the treatment of multiply drug resistant bacteria | |
| RODRiGUEZ et al. | Single-and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus | |
| Randall et al. | Prevention of wound infection following vasectomy |